In GWAS analysis, performed in pediatric ALL patients treated according to St Jude Total Therapy and Children’s Oncology Group protocols, rs10519613 (together with five other SNPs in IL15, all in strong LD, r2 > 0.5) was among the top 102 variants associated with the MRD levels at the end of induction18. This evidence concerns the gene IL15 and acute lymphoblastic leukemia.